Publications by authors named "Katrin de Graaf"

Background: The U2 small nuclear ribonucleoprotein particle (snRNP) component SF3b1/SAP155 is the only spliceosomal protein known to be phosphorylated concomitant with splicing catalysis. DYRK1A is a nuclear protein kinase that has been localized to the splicing factor compartment. Here we describe the identification of DYRK1A as a protein kinase that phosphorylates SF3b1 in vitro and in cultivated cells.

View Article and Find Full Text PDF

A novel method employing filter arrays of a cDNA expression library for the identification of substrates for protein kinases was developed. With this technique, we identified a new member of the cyclin family, cyclin L2, as a substrate of the nuclear protein kinase DYRK1A. Cyclin L2 contains an N-terminal cyclin domain and a C-terminal arginine/serine-rich domain (RS domain), which is a hallmark of many proteins involved in pre-mRNA processing.

View Article and Find Full Text PDF

The dual specificity tyrosine phosphorylated and regulated kinase (DYRK) family of protein kinases is a group of evolutionarily conserved protein kinases that have been characterized as regulators of growth and development in mammals, Drosophila and lower eukaryotes. In the present study, we have characterized three splicing variants of DYRK1B (DYRK1B-p65, DYRK1B-p69 and DYRK1B-p75) with different expression patterns and enzymic activities. DYRK1B-p65 and DYRK1B-p69 exhibited similar, but not identical, patterns of expression in mouse tissues, with the highest protein levels found in the spleen, lung, brain, bladder, stomach and testis.

View Article and Find Full Text PDF

Protein kinases of the DYRK (dual-specificity tyrosine phosphorylation-regulated kinase) family require phosphorylation of a conserved tyrosine residue in the activation loop for full activity. Here we have characterized the role of conserved amino acids that are located in the vicinity of the phosphorylated tyrosine in DYRK1A (Tyr-321). Mutation of Gln-323, but not Asn-365 or Glu-366, to either alanine, glutamate, or asparagine reduced the in vitro-kinase activity of DYRK1A towards the peptide substrate, DYRKtide, to a similar degree (15-37% of wild type) as the mutation of the phosphorylation site itself (Y321F).

View Article and Find Full Text PDF